Catalyst Wire Dossier Catalyst Wire Dossier

Oxycodone/naloxone (OXN)

oxycodone/naloxone · Mundipharma Pharmaceuticals B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oxycodone/naloxone (OXN), covering 2013-02-12 to 2013-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain [Phase 3]

See pricing